Nectero Therapeutics
Nectero Therapeutics (also operating as Nectero Medical) is a clinical-stage biopharmaceutical company developing a novel, minimally invasive treatment to stabilize growth and prevent rupture of mid-sized abdominal aortic aneurysms (AAA). Its lead investigational therapy is delivered as a single endovascular procedure intended to remodel and strengthen the aneurysm wall, offering an alternative to watchful waiting or open surgical repair. The company is backed by Norwest Venture Partners and other life-sciences investors, and maintains a corporate marketing and news presence. It does not publish a developer program, public API, SDKs, or any machine-readable API surface.
Nectero Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Healthcare, Biotechnology, Pharmaceuticals, and Therapeutics.
Nectero Therapeutics’ developer surface includes support, engineering blog, and 4 more developer resources.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Access & Security 1
Authentication, authorization, and security posture
Operate 1
Status, limits, changes, and where to get help
Company 4
The organization behind the API